In a retrospective study, serum IL-6 level > 3 pg/mL, serum IL-17A level > 4 pg/mL, and treatment regimens were found to be independent prognostic factors for PFS and OS according to multivariate analyses of selected serum cytokine levels in patients with newly diagnosed MM. Here, IL6 is linked to Miyoshi myopathy.